Which high-profile drug maker recently began allowing shareholders to vote on executive compensation at shareholder meetings?
A. Pfizer
B. AstraZeneca
C. GlaxoSmithKline
If you chose “A. Pfizer,” you’re correct.
Beginning in 2010, Pfizer shareholders will be able to approve or vote against executive compensation for the CEO, CFO and other top execs every two years, according to ABC News. The drug maker’s first shareholder meeting to be affected by the decision is tentatively scheduled for April.
Pfizer follows in the footsteps of Microsoft, which in September made the decision to give shareholders a vote on executive compensation every three years.
When you cast a vote, typically the goal is to choose the best possible option—whether you’re voting on a new school board president or a city ordinance. When was the last time you were encouraged to vote on the worst choice?
